首页 | 官方网站   微博 | 高级检索  
     

过表达TrxR1重组HEK293细胞株的构建和鉴定
引用本文:吕晓梅,周知音,朱 丽,周 吉,黄慧丹,张 超,刘晓平.过表达TrxR1重组HEK293细胞株的构建和鉴定[J].南方医科大学学报,2022,42(4):554-560.
作者姓名:吕晓梅  周知音  朱 丽  周 吉  黄慧丹  张 超  刘晓平
作者单位:皖南医学院药物筛选与评价研究所,2附属弋矶山医院生殖医学中心,安徽 芜湖 241000
摘    要:目的 构建稳定过表达硫氧还蛋白还原酶1(TrxR1)的HEK293细胞株,为TrxR1的功能研究以及靶向TrxR1药物筛选提供细胞模型。方法 通过PCR扩增,连接转化以及Sanger双脱氧测序构建并筛选出TrxR1的重组慢病毒表达载体pLVX-PuroTXNRD1,转染HEK293细胞,经嘌呤霉素筛选获得稳定转染细胞株。后续研究分为3组进行:①TrxR1过表达HEK293细胞:pLVX-Puro-TXNRD1载体稳定转染细胞;②对照HEK293细胞:pLVX-Puro空载病毒载体稳定转染细胞;③正常HEK293细胞;通过RT-qPCR、Western blot实验检测上述3组细胞中TrxR1的mRNA以及蛋白表达情况;通过胰岛素终点法以及TRFS-green探针成像检测上述3种细胞内TrxR1的酶活力;通过CCK8实验检测上述3种细胞对TrxR1特异性抑制剂auranofin的敏感性。结果 构建载体经DNA测序,成功获得插入TrxR1的重组慢病毒表达载体pLVX-Puro-TXNRD1。与HEK293以及HEK293-NC细胞相比,HEK293-TrxR1-OE细胞中TrxR1的mRNA和蛋白高表达,且酶活力也同样显著上升(P<0.005);而与HEK293以及HEK293-NC细胞相比,auranofin对HEK293-TrxR1-OE细胞中TrxR1酶活力以及细胞增殖的抑制效率均显著下降(P<0.005)。结论 通过构建pLVX-Puro-TXNRD1慢病毒载体,成功获得过表达TrxR1酶的HEK293细胞株,该细胞对特异性靶向TrxR1的抑制剂的抗增殖作用具有抵抗,因而可用于靶向TrxR1药物的筛选。

关 键 词:硫氧还蛋白还原酶1  慢病毒包装  过表达  细胞模型  

Construction and identification of a HEK293 cell line with stable TrxR1 overexpression
Lü Xiaomei,ZHOU Zhiyin,ZHU Li,ZHOU Ji,HUANG Huidan,ZHANG Chao,LIU Xiaoping.Construction and identification of a HEK293 cell line with stable TrxR1 overexpression[J].Journal of Southern Medical University,2022,42(4):554-560.
Authors:LÜ Xiaomei  ZHOU Zhiyin  ZHU Li  ZHOU Ji  HUANG Huidan  ZHANG Chao  LIU Xiaoping
Affiliation:Center of Drug Screening and Evaluation, Wannan Medical College, Wuhu 241000, China; Center for Reproductive Medicine, First Affiliated Hospital of Wannan Medical College, Wuhu 241000, China
Abstract:Objective To construct a HEK293 cell line stably overexpressing TrxR1 as a cell model for functional study of TrxR1 and screening of TrxR1-targeting drugs. Methods TrxR1 gene was amplified by PCR and ligated with the lentivirus expression vector pLVX-Puro, which was transformed into Escherichia coli and identified by Sanger dideoxy sequencing. HEK293 cells were infected with the recombinant lentivirus vector (pLVX-Puro-TXNRD1) and screened with Puromycin for cell clones with stable TrxR1 overexpression (HEK293-TrxR1-OE cells). HEK293-TrxR1-OE cells, along with HEK293 cells infected with pLVX-Puro vector (HEK293-NC) and normal HEK293 cells, were tested for mRNA and protein expression levels of TrxR1 using RT-qPCR and Western blotting. TrxR1 enzyme activity in the cells was evaluated with insulin endpoint assay and TRFS-green probe imaging. The sensitivity of the cells to auranofin, a specific TrxR1 inhibitor, was determined with CCK8 assay. Results TrxR1 gene was successfully inserted into the lentiviral vector pLVX-Puro as confirmed by DNA sequencing. The enzyme activity and mRNA and protein expression levels of TrxR1 were significantly higher in HEK293-TrxR1-OE cells than in HEK293 and HEK293-NC cells (P<0.005). The inhibitory effects of auranofin on proliferation and cellular TrxR1 enzyme activity were significantly attenuated in HEK293-TrxR1-OE cells as compared with HEK293 and HEK293-NC cells (P<0.005). Conclusion We successfully obtained a HEK293 cell line with stable TrxR1 overexpression, which shows resistance to auranofin and can be used for screening TrxR1 targeting drugs.
Keywords:thioredoxin reductase 1  lentiviral packaging  overexpression  cell model  
点击此处可从《南方医科大学学报》浏览原始摘要信息
点击此处可从《南方医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号